EGI
EAM Global Investors Portfolio holdings
AUM
$386M
1-Year Return
167.74%
This Quarter Return
+51.03%
1 Year Return
+167.74%
3 Year Return
+1,982.88%
5 Year Return
+28,423.56%
10 Year Return
–
AUM
$205M
AUM Growth
+$11.7M
(+6.1%)
Cap. Flow
-$10.8M
Cap. Flow
% of AUM
-5.28%
Top 10 Holdings %
Top 10 Hldgs %
15.98%
Holding
210
New
75
Increased
3
Reduced
46
Closed
60
Top Buys
| 1 |
GeoPark
GPRK
|
+$4.85M |
| 2 |
TBCH
Turtle Beach Corporation Common Stock
TBCH
|
+$2.48M |
| 3 |
LivePerson
LPSN
|
+$1.9M |
| 4 |
ROCC
Ranger Oil Corporation Class A Common Stock
ROCC
|
+$1.78M |
| 5 |
Tandem Diabetes Care
TNDM
|
+$1.73M |
Top Sells
| 1 |
VanEck India Growth Leaders ETF
GLIN
|
+$9.09M |
| 2 |
SODA
SodaStream International Ltd
SODA
|
+$6.1M |
| 3 |
MZOR
Mazor Robotics Ltd.
MZOR
|
+$3.96M |
| 4 |
AnaptysBio
ANAB
|
+$2M |
| 5 |
Medifast
MED
|
+$1.79M |
Sector Composition
| 1 | Healthcare | 25.56% |
| 2 | Technology | 25.47% |
| 3 | Consumer Discretionary | 14.85% |
| 4 | Industrials | 9.4% |
| 5 | Energy | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Gyre Therapeutics
GYRE
$711M
| – | – |
-3,330
| Closed | -$644K |
|
152
Alamo Group
ALG
$2.49B
| – | – |
-13,978
| Closed | -$1.54M |
|
|
153
AnaptysBio
ANAB
$655M
| – | – |
-19,179
| Closed | -$2M |
|
154
Abercrombie & Fitch
ANF
$4.12B
| – | – |
-41,975
| Closed | -$1.02M |
|
155
Digital Turbine
APPS
$501M
| – | – |
-390,672
| Closed | -$785K |
|
156
Assembly Biosciences
ASMB
$168M
| – | – |
-1,995
| Closed | -$1.18M |
|
157
Blue Bird Corp
BLBD
$1.84B
| – | – |
-51,605
| Closed | -$1.22M |
|
158
Pathward Financial
CASH
$1.72B
| – | – |
-31,719
| Closed | -$1.16M |
|
159
Clearside Biomedical
CLSD
$25.1M
| – | – |
-84,199
| Closed | -$903K |
|
160
Collegium Pharmaceutical
COLL
$1.18B
| – | – |
-42,193
| Closed | -$1.08M |
|
161
CytomX Therapeutics
CTMX
$330M
| – | – |
-48,575
| Closed | -$1.38M |
|
162
Casella Waste Systems
CWST
$5.79B
| – | – |
-52,184
| Closed | -$1.22M |
|
163
Denny's
DENN
$264M
| – | – |
-93,456
| Closed | -$1.44M |
|
164
DXP Enterprises
DXPE
$1.85B
| – | – |
-31,354
| Closed | -$1.22M |
|
165
Esperion Therapeutics
ESPR
$573M
| – | – |
-23,376
| Closed | -$1.69M |
|
166
Global Industrial
GIC
$1.42B
| – | – |
-26,936
| Closed | -$769K |
|
167
Inogen
INGN
$231M
| – | – |
-5,939
| Closed | -$730K |
|
168
Iovance Biotherapeutics
IOVA
$821M
| – | – |
-64,545
| Closed | -$1.09M |
|
169
Kadant
KAI
$3.69B
| – | – |
-15,790
| Closed | -$1.49M |
|
170
Kura Oncology
KURA
$711M
| – | – |
-52,885
| Closed | -$992K |
|
171
LivaNova
LIVN
$3.07B
| – | – |
-12,501
| Closed | -$1.11M |
|
172
Monarch Casino & Resort
MCRI
$1.9B
| – | – |
-25,477
| Closed | -$1.08M |
|
173
Modine Manufacturing
MOD
$7.86B
| – | – |
-49,546
| Closed | -$1.05M |
|
174
Nomad Foods
NOMD
$2.12B
| – | – |
-62,783
| Closed | -$988K |
|
175
Novavax
NVAX
$1.3B
| – | – |
-24,315
| Closed | -$1.02M |
|